Ventas (VTR) – Analysts’ Recent Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Ventas (NYSE: VTR) in the last few weeks:

• 8/14/2026 – Ventas had its price target raised by Royal Bank Of Canada from $98.00 to $99.00. They now have an “outperform” rating on the stock.
• 8/11/2026 – Ventas had its price target raised by BMO Capital Markets from $105.00 to $107.00. They now have an “outperform” rating on the stock.
• 8/4/2026 – Ventas had its price target raised by Citigroup Inc. from $100.00 to $110.00. They now have a “buy” rating on the stock.
• 7/31/2026 – Ventas had its price target raised by Cantor Fitzgerald from $97.00 to $102.00. They now have an “overweight” rating on the stock.
• 7/22/2026 – Ventas had its price target raised by Mizuho from $98.00 to $104.00. They now have an “outperform” rating on the stock.
• 7/21/2026 – Ventas was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 7/8/2026 – Ventas was downgraded by Weiss Ratings from “buy (b-)” to “hold (c+)”.
• 7/7/2026 – Ventas is now covered by Barclays PLC. They set an “equal weight” rating and a $99.00 price target on the stock.
• 6/24/2026 – Ventas had its “buy (b-)” rating reaffirmed by Weiss Ratings.
• 6/18/2026 – Ventas had its price target lowered by Scotiabank from $95.00 to $88.00. They now have a “sector perform” rating on the stock.

Insiders Place Their Bets

In other Ventas news, Director Michael J. Embler purchased 2,500 shares of the stock in a transaction on Wednesday, June 3rd. The shares were purchased at an average price of $78.81 per share, with a total value of $197,025.00. Following the acquisition, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This represents a 14.97% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.53% of the stock is owned by corporate insiders.

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.